1992PubMedRequires access

[Potential for the clinical use of intranasal rifathyroin for diagnosis and treatment].

Starkova Nt, Butrova Sa, Surkov Si, Kotova Ga, Nazarov An, Bobrovskaia Ta

Open publisher page 0 citations

Abstract

It has been shown that stimulated TSH and prolactin levels in intranasal administration of rifathyroin are comparable with the results of i.v. administration of the drug. Intranasal administration can be used for both therapeutic and diagnostic purposes.

About this research paper

What this paper is about

It has been shown that stimulated TSH and prolactin levels in intranasal administration of rifathyroin are comparable with the results of i.v. administration of the drug. Intranasal administration can be used for both therapeutic and diagnostic purposes.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

It has been shown that stimulated TSH and prolactin levels in intranasal administration of rifathyroin are comparable with the results of i.v. administration of the drug. Intranasal administration can be used for both therapeutic and diagnostic purposes.

Key concepts: Nasal administration, Administration (probate law), Medicine, Drug administration, Food and drug administration, Prolactin, Drug, Pharmacology

Related papers

Back to paper searchBrowse research topicsOriginal source
[Potential for the clinical use of intranasal rifathyroin for diagnosis and treatment]. — Research Paper | ScholarLens